Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of YMAB will rise by +10.20% over the next 2 Weeks and hit $9.49 by Monday, September 29, 2025. In that time frame, YMAB's share price is expected to range between $8.09 and $10.78.
BearishAverageBullishYMAB shares rose +0.23% in Tuesday, September 16, 2025's trading session, rising from a previous close of $8.59 to move at $8.61. The stock demonstrated notable intraday movement (see YMAB's key stats for a full breakdown), fluctuating between $8.61 and $8.61, a 0 trading range. While recent weeks have seen some volatility, YMAB has managed to secure a +0.58% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 760.7K shares changing hands, 269.31K more than the previous session. This amounted to $6.55M in total market activity.
Will YMAB Continue Its Upward Trend?
According to analyst ratings and projections for YMAB, Y-mAbs Therapeutics, Inc. shares are anticipated to increase by +24.41%, potentially reaching $11.39 per share by September 29, 2025. Short-term technical indicators currently suggest a neutral sentiment for YMAB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the YMAB stock forecast, now is a good time to buy YMAB stock because its current trading price is -14.19% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on YMAB covering social and institutional perspectives.
YMAB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into YMAB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 77.65% to 83.83%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 64.14%, suggests strong medium-term momentum. However, the 100-day RSI, at 54.34%, maintains a neutral outlook for the long term. Insights into YMAB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Y-mAbs Therapeutics, Inc. Monthly Forecast 2025–2026
October 2025
According to our latest forecast models, Y-mAbs Therapeutics, Inc. (YMAB) is positioned to show a strong performance in October 2025. The price is predicted to move between $4.17 and $8.17, settling at an average of $6.30. This could translate to a -26.83% loss.
November 2025
Based on current market signals, Y-mAbs Therapeutics, Inc. is projected to trend november 2025. We forecast a trading range from $2.90 to $7.64, with a likely average price of $4.93. Investors could expect a potential return of -42.74%.
December 2025
Our predictive algorithms indicate Y-mAbs Therapeutics, Inc. stock may see a shift in December 2025. The expected range spans $0.28–$6.12, with an average target of $3.19. This represents a cautious outlook and a possible loss of -62.95%.
January 2026
Analyzing established trends, Y-mAbs Therapeutics, Inc. looks set to move in January 2026. Projections place the stock between $0.37 and $4.46, averaging around $2.36. This suggests a -72.59% loss from current levels.
February 2026
Market indicators suggest Y-mAbs Therapeutics, Inc. could experience notable changes during February 2026. Prices could fluctuate within $0.53 to $4.57, with a midpoint forecast of $2.54. The stock might deliver a -70.50% loss.
March 2026
Forecasting for March 2026, models estimate that Y-mAbs Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.05 and $3.74, averaging $1.80. This signals a cautious trajectory with potential returns around -79.09%.
April 2026
According to our latest forecast models, Y-mAbs Therapeutics, Inc. (YMAB) is positioned to show a strong performance in April 2026. The price is predicted to move between $0.11 and $3.73, settling at an average of $1.94. This could translate to a -77.47% loss.
May 2026
Based on current market signals, Y-mAbs Therapeutics, Inc. is projected to trend may 2026. We forecast a trading range from $0.00 to $3.51, with a likely average price of $1.36. Investors could expect a potential return of -84.20%.
June 2026
Our predictive algorithms indicate Y-mAbs Therapeutics, Inc. stock may see a shift in June 2026. The expected range spans $0.00–$2.70, with an average target of $0.97. This represents a cautious outlook and a possible loss of -88.73%.
July 2026
Analyzing established trends, Y-mAbs Therapeutics, Inc. looks set to move in July 2026. Projections place the stock between $0.00 and $2.80, averaging around $0.87. This suggests a -89.90% loss from current levels.
August 2026
Market indicators suggest Y-mAbs Therapeutics, Inc. could experience notable changes during August 2026. Prices could fluctuate within $0.00 to $2.61, with a midpoint forecast of $0.69. The stock might deliver a -91.99% loss.
September 2026
Forecasting for September 2026, models estimate that Y-mAbs Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.36, averaging $0.68. This signals a cautious trajectory with potential returns around -92.10%.
YMAB's history of dividends and stock splits also plays a role in long-term investor confidence.